Found: 10
Select item for more details and to access through your institution.
Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.800283
- By:
- Publication type:
- Article
The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01556
- By:
- Publication type:
- Article
LL37/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy.
- Published in:
- FASEB Journal, 2024, v. 38, n. 11, p. 1, doi. 10.1096/fj.202400656R
- By:
- Publication type:
- Article
Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02640-z
- By:
- Publication type:
- Article
Circ_SAR1A regulates the malignant behavior of lung cancer cells via the miR‐21‐5p/TXNIP axis.
- Published in:
- Journal of Clinical Laboratory Analysis, 2022, v. 36, n. 5, p. 1, doi. 10.1002/jcla.24366
- By:
- Publication type:
- Article
Magnetic black phosphorus microbubbles for targeted tumor theranostics.
- Published in:
- Nanophotonics (21928606), 2021, v. 10, n. 12, p. 3339, doi. 10.1515/nanoph-2021-0085
- By:
- Publication type:
- Article
LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1332922
- By:
- Publication type:
- Article
Integrative computational approach identifies immune‐relevant biomarkers in ulcerative colitis.
- Published in:
- FEBS Open Bio, 2022, v. 12, n. 2, p. 500, doi. 10.1002/2211-5463.13357
- By:
- Publication type:
- Article
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 1, p. 167, doi. 10.1007/s13402-022-00742-0
- By:
- Publication type:
- Article
Targeting TRIP13 for overcoming anticancer drug resistance (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8639
- By:
- Publication type:
- Article